Targeting Chronic Myelogenous Leukemia with Imatinib and Glycyrrhizic Acid Combination Therapy
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Keyword
School of MedicineDate
2020
Metadata
Show full item recordTitle
Targeting Chronic Myelogenous Leukemia with Imatinib and Glycyrrhizic Acid Combination TherapyAbstract
Examining the efficacy of an imatinib and glycyrrhizic acid combination treatment on chronic myelogenous leukemia cell lines. As well as examining the mechanism of action of glycyrrhizic acid.Collections